(S)-N-hydroxy-N-(2-(5-((4((2-(hydroxymethyl)-1H-imidazol-1-yl)methyl)phenyl)ethynyl)-1H-benzo[d][1,2,3]triazol-1-y1)-1-(methylthio)ethyl)formamide

ID: ALA4776397

Chembl Id: CHEMBL4776397

PubChem CID: 162643735

Max Phase: Preclinical

Molecular Formula: C22H20N6O3S

Molecular Weight: 448.51

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CS[C@@H](Cn1nnc2cc(C#Cc3ccc(-n4ccnc4CO)cc3)ccc21)N(O)C=O

Standard InChI:  InChI=1S/C22H20N6O3S/c1-32-22(28(31)15-30)13-27-20-9-6-17(12-19(20)24-25-27)3-2-16-4-7-18(8-5-16)26-11-10-23-21(26)14-29/h4-12,15,22,29,31H,13-14H2,1H3/t22-/m0/s1

Standard InChI Key:  BLRFUTZJCGCZOH-QFIPXVFZSA-N

Alternative Forms

  1. Parent:

    ALA4776397

    ---

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

lpxC UDP-3-O-acyl-GlcNAc deacetylase (700 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 448.51Molecular Weight (Monoisotopic): 448.1318AlogP: 2.05#Rotatable Bonds: 7
Polar Surface Area: 109.30Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.85CX Basic pKa: 5.03CX LogP: 2.57CX LogD: 2.44
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.15Np Likeness Score: -1.43

References

1. Furuya T,Shapiro AB,Comita-Prevoir J,Kuenstner EJ,Zhang J,Ribe SD,Chen A,Hines D,Moussa SH,Carter NM,Sylvester MA,Romero JAC,Vega CV,Sacco MD,Chen Y,O'Donnell JP,Durand-Reville TF,Miller AA,Tommasi RA.  (2020)  N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assay.,  28  (24): [PMID:33160146] [10.1016/j.bmc.2020.115826]

Source